Ladenburg Thalmann Financial Services’s Sonoma Pharmaceuticals SNOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1K Hold
8
﹤0.01% 5228
2019
Q3
$1K Hold
8
﹤0.01% 5154
2019
Q2
$1K Hold
8
﹤0.01% 5148
2019
Q1
$1K Hold
8
﹤0.01% 5105
2018
Q4
$1K Hold
8
﹤0.01% 5081
2018
Q3
$2K Sell
8
-13
-62% -$4.72K ﹤0.01% 4906
2018
Q2
$15K Hold
21
﹤0.01% 4009
2018
Q1
$15K Hold
21
﹤0.01% 4009
2017
Q4
$21K Buy
21
+19
+950% +$16.3K ﹤0.01% 3772
2017
Q3
$2K Buy
2
+1
+100% +$1.08K ﹤0.01% 4692
2017
Q2
$1K Hold
1
﹤0.01% 4765
2017
Q1
$1K Hold
1
﹤0.01% 4739
2016
Q4
$1K Hold
1
﹤0.01% 4702
2016
Q3
$0 Hold
1
﹤0.01% 4862
2016
Q2
$0 Hold
1
﹤0.01% 4830
2016
Q1
$0 Hold
1
﹤0.01% 4790
2015
Q4
$1K Hold
1
﹤0.01% 4543
2015
Q3
$1K Hold
1
﹤0.01% 4454
2015
Q2
$1K Sell
1
-11
-92% -$10.3K ﹤0.01% 4524
2015
Q1
$9K Buy
12
+11
+1,100% +$9.35K ﹤0.01% 3708
2014
Q4
$1K Hold
1
﹤0.01% 4239
2014
Q3
$2K Hold
1
﹤0.01% 3691
2014
Q2
$2K Hold
1
﹤0.01% 3654
2014
Q1
$3K Hold
1
﹤0.01% 3430
2013
Q4
$2K Hold
1
﹤0.01% 3520
2013
Q3
$2K Hold
1
﹤0.01% 3471
2013
Q2
$2K Buy
+1
New +$3.57K ﹤0.01% 3341

Other funds holding SNOA

Ladenburg Thalmann Financial Services's SNOA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Sonoma Pharmaceuticals (SNOA) position steady in Q4 2019 at 8 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5228.

Ladenburg Thalmann Financial Services first reported a position in SNOA in Q2 2013 and has held it in 27 quarters since. The position peaked at $21K in Q4 2017. 13 funds tracked by Wall St. Rank hold SNOA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 8 shares of Sonoma Pharmaceuticals worth $1K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Sonoma Pharmaceuticals share count unchanged in Q4 2019.
  • Sonoma Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5228 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Sonoma Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Sonoma Pharmaceuticals position peaked at $21K in Q4 2017.
  • 13 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.